Floatz logo

PLASMALYTE A

Morbid Obesity

University of Auckland, New ZealandmixtureN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

26 Active assets in the Morbid Obesity cohort.

Asset / SponsorPhaseRating
PROPOFOL
G.Gennimatas General Hospital
Phase 4BBB
Bxcl501
Cairo University
Phase 4BB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Amany Ahmed Eissa
Phase 4BB
Phentermine
University of Colorado, Denver
Phase 4BB
NEPENTHE
Kirsehir Ahi Evran Universitesi
Phase 4BB

View all 50 →

Same molecule, other indications

PLASMALYTE A is also rated in:

stroke disorderDormant
CC
Indicative ·
41 / 100
View asset →
cirrhosis of liverDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →